Anticoagulant drugs increase natural killer cell activity in lung cancer

V Bobek1, M Boubelik, A Fiserová

  • 1Third Faculty of Medicine, Charles University Prague, Department of Molecular Biology, Ruska 87, 10034 Prague, Czech Republic. vbobek@centrum.cz

Abstract

Insights

Anticoagulants like heparin and warfarin enhance natural killer (NK) cell activity in cancer patients and animal models. This study reveals a novel immune-boosting effect beyond their blood-thinning properties.

Area of Science:

  • Immunology
  • Pharmacology
  • Oncology

Background:

  • Anticoagulants show promise in preventing metastasis and prolonging survival in preclinical and early clinical studies.
  • Limited research exists on the direct impact of anticoagulants on the immune system.

Purpose of the Study:

  • To investigate the effects of warfarin, unfractionated heparin, low molecular weight heparins (LMWHs), and acetylsalicylic acid on natural killer (NK) cell functional activity.

Main Methods:

  • Compared NK cell cytotoxic activity in early-stage non-small-cell lung cancer patients versus healthy volunteers.
  • Conducted in vitro studies with peripheral blood mononuclear cells (PBMC) and ex vivo studies in tumor-bearing animals.

Main Results:

  • Lung cancer patients exhibited significantly lower NK cell cytotoxicity than healthy donors.
  • Unfractionated heparin and LMWHs (fraxiparine) activated NK cells in vitro and ex vivo in lung cancer patients.
  • Therapy with unfractionated heparin potentiated NK cell activity in a mouse model of Lewis lung carcinoma.

Conclusions:

  • LMWHs and other anticoagulants enhance NK cell activation and effector function in cancer patients and animal models.
  • This immune-modulatory effect is a newly identified property of anticoagulants, distinct from their anticoagulant actions.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...